ARCHIVES

New NCI advisory Boards Appointed, Begin Review Of NCI Programs

This article is from The Cancer Letter archive.

Vol. 22 No. 13 | March 29, 1996

Download PDF Visit The Full Archive

Related Articles

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

In Brief: Eight Site Visits at Prospective Comprehensive Centers Scheduled For NCCAB Members In ’75, 76

July 4, 1975

Shalala Named President, University Of Miami.

November 24, 2000

UCSF Gets $20 Million For Stem Cell Research Building

February 4, 2011

Vanderbilt Lung Cancer Trial For Never Smokers Online

September 25, 2009

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003